Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Fabrinet
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-84.2% vs price
Base Case (Median)
-65.7% vs price
Bull Case (75th pct.)
-37.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $49.61 | -88.0% | High (40%) |
| PE Comparable | $330.99 | -20.1% | Medium (25%) |
| Growth Trajectory DCF | $386.70 | -6.6% | Medium (20%) |
| Graham Number | $141.85 | -65.7% | Low (10%) |
| EV/EBITDA | $183.68 | -55.6% | Medium (20%) |
| EV/FCF | $11.93 | -97.1% | Medium (20%) |
| Earnings Power Value | $81.12 | -80.4% | Medium (50%) |
Based on 7 out of 7 methods, FN appears overvalued at the current price of $414.05. The base case fair value of $141.85 implies 65.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.